Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-21-000029

Chief R&D Officer gave up 406 shares (to pay taxes)

  • Chief R&D Officer acquired 1,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Scopelianos Angelo · Chief R&D Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-16 Grant or award : show line 1 in the form +1,325 7,452 D
2021-02-17 Shares withheld for taxes : show line 2 in the form −406 $18.71 $7,596 7,046 D
Loading xslF345X03/wf-form4_161368721919283.xml…